Intellia Therapeutics(NTLA) - 2023 Q4 - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Conference Call February 22, 2024 8:00 AM ET Company Participants Ian Karp - SVP, IR and Corporate Communications John Leonard - President and CEO David Lebwohl - EVP and CMO Laura Sepp-Lorenzino - EVP and CSO Glenn Goddard - EVP and Chief Financial Officer Eliana Clark - EVP and CTO Conference Call Participants Maury Raycroft - Jefferies Unidentified Analyst - RBC Greg Harrison - Bank of America Unidentified Analyst - Barclays Troy Langford - TD Co ...